| Year |
Citation |
Score |
| 2012 |
Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, Rees JR, Supattapone S. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proceedings of the National Academy of Sciences of the United States of America. 109: E1938-46. PMID 22711839 DOI: 10.1073/Pnas.1206999109 |
0.677 |
|
| 2012 |
Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proceedings of the National Academy of Sciences of the United States of America. 109: 8546-51. PMID 22586108 DOI: 10.1073/Pnas.1204498109 |
0.658 |
|
| 2012 |
Walsh DJ, Noble GP, Piro JR, Supattapone S. Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein. Preparative Biochemistry & Biotechnology. 42: 77-86. PMID 22239709 DOI: 10.1080/10826068.2011.564256 |
0.622 |
|
| 2011 |
Piro JR, Wang F, Walsh DJ, Rees JR, Ma J, Supattapone S. Seeding specificity and ultrastructural characteristics of infectious recombinant prions. Biochemistry. 50: 7111-6. PMID 21776987 DOI: 10.1021/Bi200786P |
0.629 |
|
| 2011 |
Piro JR, Supattapone S. Photodegradation illuminates the role of polyanions in prion infectivity. Prion. 5: 49-51. PMID 21646861 DOI: 10.4161/Pri.5.2.16155 |
0.654 |
|
| 2011 |
Piro JR, Harris BT, Supattapone S. In situ photodegradation of incorporated polyanion does not alter prion infectivity. Plos Pathogens. 7: e1002001. PMID 21304885 DOI: 10.1371/Journal.Ppat.1002001 |
0.683 |
|
| 2009 |
Supattapone S, Piro JR, Rees JR. Complex polyamines: unique prion disaggregating compounds. Cns & Neurological Disorders Drug Targets. 8: 323-8. PMID 19702574 DOI: 10.2174/187152709789541952 |
0.636 |
|
| 2009 |
Piro JR, Harris BT, Nishina K, Soto C, Morales R, Rees JR, Supattapone S. Prion protein glycosylation is not required for strain-specific neurotropism. Journal of Virology. 83: 5321-8. PMID 19297485 DOI: 10.1128/Jvi.02502-08 |
0.671 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Piro JR, Suidan GL, Quan J, Pi Y, O'Neill SM, Ilardi M, Pozdnyakov N, Lanz TA, Xi H, Bell RD, Samad TA. Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury. Journal of Neuroinflammation. 15: 142. PMID 29759062 DOI: 10.1186/S12974-018-1166-9 |
0.298 |
|
| 2017 |
Terrone G, Pauletti A, Salamone A, Rizzi M, Villa BR, Porcu L, Sheehan MJ, Guilmette E, Butler CR, Piro JR, Samad TA, Vezzani A. Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet. Epilepsia. PMID 29171003 DOI: 10.1111/Epi.13950 |
0.288 |
|
| 2018 |
McAllister LA, Butler CR, Mente S, O'Neil SV, Fonseca KR, Piro JR, Cianfrogna JA, Foley TL, Gilbert AM, Harris AR, Helal CJ, Johnson DS, Montgomery JI, Nason DM, Noell S, et al. Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation. Journal of Medicinal Chemistry. PMID 29498843 DOI: 10.1021/Acs.Jmedchem.8B00070 |
0.288 |
|
| 2017 |
Butler CR, Beck EM, Harris AR, Huang Z, McAllister LA, Am Ende CW, Fennell KF, Foley TL, Fonseca KR, Hawrylik SJ, Johnson DS, Knafels JD, Mente S, Noell S, Pandit J, ... ... Piro JR, et al. Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase. Journal of Medicinal Chemistry. PMID 29148769 DOI: 10.1021/Acs.Jmedchem.7B01531 |
0.271 |
|
| 2012 |
Piro JR, Benjamin DI, Duerr JM, Pi Y, Gonzales C, Wood KM, Schwartz JW, Nomura DK, Samad TA. A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease. Cell Reports. 1: 617-23. PMID 22813736 DOI: 10.1016/J.Celrep.2012.05.001 |
0.271 |
|
| 2019 |
Biber K, Bhattacharya A, Campbell BM, Piro JR, Rohe M, Staal RGW, Talanian RV, Möller T. Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development. Frontiers in Pharmacology. 10: 840. PMID 31507408 DOI: 10.3389/Fphar.2019.00840 |
0.263 |
|
| 2019 |
Zhang L, Butler CR, Maresca KP, Takano A, Nag S, Jia Z, Arakawa R, Piro J, Samad T, Smith DL, Nason DM, O'Neil SV, McAllister LA, Schildknegt K, Trapa P, et al. Identification and development of an irreversible monoacylglycerol lipase (MAGL) positron emission tomography (PET) radioligand with high specificity. Journal of Medicinal Chemistry. PMID 31483137 DOI: 10.1021/Acs.Jmedchem.9B00847 |
0.255 |
|
| 2022 |
Arakawa R, Takano A, Nag S, Jia Z, Amini N, Maresca KP, Zhang L, Keliher EJ, Butler CR, Piro JR, Samad TA, Smith D, Nason D, O'Neil S, Trapa P, et al. Target occupancy study and whole-body dosimetry with a MAGL PET ligand [C]PF-06809247 in non-human primates. Ejnmmi Research. 12: 13. PMID 35244788 DOI: 10.1186/s13550-022-00882-2 |
0.109 |
|
| Hide low-probability matches. |